158 related articles for article (PubMed ID: 9299260)
1. Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma.
Liu FS; Ho ES; Shih RT; Shih A
Gynecol Oncol; 1997 Sep; 66(3):449-53. PubMed ID: 9299260
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the estrogen-receptor gene in endometrial carcinoma.
Kohler MF; Berkholz A; Risinger JI; Elbendary A; Boyd J; Berchuck A
Obstet Gynecol; 1995 Jul; 86(1):33-7. PubMed ID: 7784019
[TBL] [Abstract][Full Text] [Related]
3. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).
Geisler JP; Hatterman-Zogg MA; Rathe JA; Lallas TA; Kirby P; Buller RE
Hum Mutat; 2001 Oct; 18(4):337-44. PubMed ID: 11668617
[TBL] [Abstract][Full Text] [Related]
6. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
7. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
Barker DF
Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
[TBL] [Abstract][Full Text] [Related]
8. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
9. Novel germline mutations of hMSH2 in a patient with hereditary nonpolyposis colorectal cancer (HNPCC) and in a patient with six primary cancers.
Okamura S; Koyama K; Miyoshi Y; Monden M; Takami M
J Hum Genet; 1998; 43(2):143-5. PubMed ID: 9621522
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
Kringen P; Egedal S; Pedersen JC; Harbitz TB; Tveit KM; Berg K; Børresen-Dale AL; Andersen TI
Electrophoresis; 2002 Dec; 23(24):4085-91. PubMed ID: 12481264
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 germline mutations in Indian familial breast cancer.
Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
[TBL] [Abstract][Full Text] [Related]
13. [Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
Zhou YZ; Sun Q; Lin SQ; Wang J; Liu B; Li JX; Zhou YD; Ye J; Han H; Fang FD
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):294-8. PubMed ID: 15059511
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
Montagna M; Santacatterina M; Torri A; Menin C; Zullato D; Chieco-Bianchi L; D'Andrea E
Oncogene; 1999 Jul; 18(28):4160-5. PubMed ID: 10435598
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
17. Dideoxy fingerprinting assay for BRCA1 mutation analysis.
Lancaster JM; Berchuck A; Futreal PA; Wiseman RW
Mol Carcinog; 1997 Jul; 19(3):176-9. PubMed ID: 9254884
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
19. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 germline mutation presenting as an adenocarcinoma of unknown primary.
Klein P; Prolla G; Wallach R; Melamed J; Muggia FM
Cancer J; 2000; 6(3):188-90. PubMed ID: 10882335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
